Differential association of uracil DNA glycosylase with SIV(SM) Vpr and Vpx proteins

Virology

Volumn 245, Issue 2, 1998, Pages 338-343

  Sleigh, Roger ^a   Sharkey, Mark ^a   Newman, Margaret A ^a   Hahn, Beatrice ^b   Stevenson, Mario ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA GLYCOSYLTRANSFERASE; VIRUS PROTEIN;

ARTICLE; CELL PROLIFERATION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032486488     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9159     Document Type: Article

References (45)

1. Bailliet J. W., Kolson D. L., Eiger G., Kim F. M., McGann K. A., Srinivasan A., Collman R. Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type I accessory genesvpr, vpunef: Virology. 200:1994;623-631.
2. Banapour B., Marthas M. L., Munn R. J., Luciw P. A. In vitro macrophage tropism of pathogenic and nonpathogenic molecular clones of simian immunodeficiency virus (SIVmac). Virology. 183:1991;12-19.
3. Bergman A. C., Björnberg O., Nord J., Nyman P. O., Rosengren A. M. The protein p30, encoded at thegag-pro. Virology. 204:1994;420-424.
4. Bouhamdan M., Benichou S., Rey F., Navarro J. M., Agostini I., Spire B., Camonis J., Slupphaug G., Vigne R., Benarous R., Sire J. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70:1996;697-704.
5. Bukrinsky M. I., Sharova N., Dempsey M. P., Stanwick T. L., Bukrinskaya A. G., Haggerty S., Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA. 89:1992;6580-6584.
6. Cohen E. A., Dehni G., Sodroski J. G., Haseltine W. A. Human immunodeficiency virusvpr. J. Virol. 64:1990;3097-3099.
7. Connor R. I., Chen B. K., Choe S., Landau N. R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206:1995;935-944.
8. Dewhurst S., Embretson J. E., Anderson D. C., Mullins J. I., Fultz P. N. Sequence analysis and acute pathogenicity of molecularly cloned SIV. Nature. 345:1990;636-640.
9. Elder J. H., Lerner D. L., Hasselkus-Light C. S., Fontenot D. J., Hunter E., Luciw P. A., Montelaro R. C., Phillips T. R. Distinct subsets of retroviruses encode dUTPase. J. Virol. 66:1992;1791-1794.
10. SM. EMBO J. 15:1996;6155-6165.
11. Focher F., Verri A., Verzeletti S., Mazarello P., Spadari S. Uracil in OriS of herpes simplex virus 1 alters its specific recognition by origin binding protein (OBP): Does virus induced uracil-DNA glycosylase play a key role in viral reactivation and replication. Chromosoma. 102:1992;S67-S71.
12. Haase A. T. Pathogenesis of lentivirus infections. Nature. 322:1986;130-136.
13. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
14. cdc2. J. Virol. 69:1995;6705-6711.
15. Heinzinger N. K., Bukrinsky M. I., Haggerty S. A., Ragland A. M., Kewalramani V., Lee M.-A., Gendelman H. E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
16. Iwabuchi K., Li B., Bautel P., Fields S. Use of the two-hybrid system to identify the domain of p53 involved in oligomerization. Oncogene. 8:1993;1693-1696.
17. 2. J. Virol. 69:1995;6304-6313.
18. Kappes J. C., Parkin J. S., Conway J. A., Kim J., Brouillette C. G., Shaw G. M., Hahn B. H. Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology. 193:1993;222-223.
19. Kornberg A., Baker T. A. DNA Replication. 1991;Freeman, New York.
20. Levy D. N., Fernandes L. S., Williams W. V., Weiner D. B. Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell. 72:1993;541-550.
21. Lewis P. F., Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:1994;510-516.
22. Li B., Fields S. Identification of mutations in p53 that affect its binding to SV40 large T antigen by using the yeast two-hybrid system. FASEB J. 7:1993;957-963.
23. Lichtenstein D. L., Rushlow K. E., Cook R. F., Raabe M. L., Swardson C. J., Kociba G. J., Issel C. J., Montelaro R. C. Replicationin vitroin vivo. J. Virol. 69:1995;2881-2888.
24. Lu Y.-L., Spearman P., Ratner L. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:1993;6542-6550.
25. McGeoch D. J. Protein sequence comparisons show that the 'pseudoproteases' encoded by poxviruses and certain retroviruses belong to the deoxyuridine triphosphatase family. Nucleic Acids Res. 18:1990;4105-4110.
26. Myers G., Korber B., Berzofsky J. A., Smith R. F. Human Retroviruses and AIDS: Theoretical Biology and Biophysics. 1992;Los Alamos National Laboratory, Los Alamos.
27. Myers L. C., Vardine G. L. DNA repair proteins. Curr. Opin. Struct. Biol. 4:1994;51-59.
28. Narayan O., Clements J. E. Biology and pathogenesis of lentiviruses. J. Gen. Virol. 70:1989;1617-1639.
29. Olsen L. C., Aasland R., Wittwer C. U., Krokan H. E., Helland D. E. Molecular cloning of human uracil-DNA glycosylase, a highly conserved DNA repair enzyme. EMBO J. 8:1989;3121-3125.
30. Paxton W., Connor R. I., Landau N. R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region ofgag. J. Virol. 67:1993;7229-7237.
31. cdc2. J. Virol. 69:1995;6859-6864.
32. Roe T., Reynolds T. C., Yu G., Brown P. O. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:1993;2099-2108.
33. Rogel M. E., Wu L. I., Emerman M. The human immunodeficiency virus type 1vpr. J. Virol. 69:1995;882-888.
34. Selig L., Benichou S., Rogel M. E., Wu L. I., Vodicka M. A., Sire J., Benarous R., Emerman M. Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of Sooty Mangabeys, but binding does not correlate with cell cycle arrest. J. Virol. 71:1997;4842-4846.
35. Slupphaug G., Markussen F-H., Olsen L. C., Aasland R., Aarsæther N., Bakke O., Krokan H. E., Helland D. E. Nuclear and mitochondrial forms of human uracil-DNA glycosylase are encoded by the same gene. Nucleic Acids Res. 21:1993;2579-2584.
36. Slupphaug G., Eftedal I., Kavli B., Bharati S., Helle N. M., Haug T., Levine D. W., Krokan H. E. Properties of a recombinant human uracil-DNA glycosylase from the UNG gene and evidence that UNG encodes the major uracil-DNA glycosylase. Biochemistry. 34:1995;128-138.
37. Sutjipto S., Kodama T., Yee J., Gettie A., Jennings M., Desrosiers R. C., Marx P. A. Characterization of monoclonal antibodies that distinguish SIV isolates from each other and HIV-1 and 2. J. Gen. Virol. 71:1990;247-249.
38. Terai C., Carson D. A. Pyrimidine nucleotide and nucleic acid synthesis in human monocytes and macrophages. Exp. Cell. Res. 193:1991;375-381.
39. Threadgill D. S., Steagall W. K., Flaherty M. T., Fuller F. J., Perry S. T., Rushlow K. E., Le Grice S. F. J., Payne S. L. Characterization of equine infectious anemia virus dUTPase: Growth properties of a dUTPase-deficient mutant. J. Virol. 67:1993;2592-2600.
40. Turelli P., Petursson G., Guiguen F., Mornex J.-F., Vigne R., Querat G. Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J. Virol. 70:1996;1213-1217.
41. Verri A., Mazarello P., Biamonti G., Spadari S., Focher F. The specific binding of nuclear protein(s) to the cAMP responsive element (CRE) sequence TGACGTCA is reduced by the misincorporation of U and decreased by the deamination of C. Nucleic Acids Res. 18:1990;5775-5780.
42. Wagaman P. C., Hasselkus-Light C. S., Henson M., Lerner D. L., Phillips T. R., Elder J. H. Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). Virology. 196:1993;451-457.
43. Weinberg J. B., Matthews T. J., Cullen B. R., Malim M. H. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174:1991;1477-1482.
44. Wu X., Conway J. A., Kim J., Kappes J. C. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 gag precursor protein. J. Virol. 68:1994;6161-6169.
45. Yu X.-F., Ito S., Essex M., Lee T.-H. A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature. 335:1988;262-265.